"Interleukin-1beta" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An interleukin-1 subtype that is synthesized as an inactive membrane-bound pro-protein. Proteolytic processing of the precursor form by CASPASE 1 results in release of the active form of interleukin-1beta from the membrane.
| Descriptor ID |
D053583
|
| MeSH Number(s) |
D12.644.276.374.465.010.600 D12.644.276.374.500.400.600 D12.776.467.374.465.010.600 D12.776.467.374.500.400.600 D23.529.374.465.131.600 D23.529.374.500.400.600
|
| Concept/Terms |
Interleukin-1beta- Interleukin-1beta
- Interleukin 1beta
- IL-1 beta
- Interleukin-1 beta
- Interleukin 1 beta
- Catabolin
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-1beta".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-1beta".
This graph shows the total number of publications written about "Interleukin-1beta" by people in this website by year, and whether "Interleukin-1beta" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 2 | 3 | 5 |
| 2008 | 2 | 3 | 5 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 3 | 3 |
| 2011 | 0 | 4 | 4 |
| 2012 | 0 | 4 | 4 |
| 2013 | 1 | 1 | 2 |
| 2014 | 2 | 7 | 9 |
| 2015 | 0 | 3 | 3 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 4 | 5 |
| 2018 | 2 | 1 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 4 | 4 |
| 2021 | 1 | 1 | 2 |
| 2023 | 0 | 3 | 3 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-1beta" by people in Profiles.
-
Identification of CDK4/6 Inhibitors as Small Molecule NLRP3 Inflammasome Activators that Facilitate IL-1ß Secretion and T Cell Adjuvanticity. J Med Chem. 2024 Sep 12; 67(17):14974-14985.
-
BCG vaccination alters the epigenetic landscape of progenitor cells in human bone marrow to influence innate immune responses. Immunity. 2024 Sep 10; 57(9):2095-2107.e8.
-
Epithelial IFN? signalling and compartmentalized antigen presentation orchestrate gut immunity. Nature. 2023 Nov; 623(7989):1044-1052.
-
Endosomal trafficking of two-pore K+ efflux channel TWIK2 to plasmalemma mediates NLRP3 inflammasome activation and inflammatory injury. Elife. 2023 05 09; 12.
-
Intergenerational Perioperative Neurocognitive Disorder in Young Adult Male Rats with Traumatic Brain Injury. Anesthesiology. 2023 04 01; 138(4):388-402.
-
NLRP3 Inflammasome Mediates Immune-Stromal Interactions in Vasculitis. Circ Res. 2021 10 15; 129(9):e183-e200.
-
The AIM2 and NLRP3 inflammasomes trigger IL-1-mediated antitumor effects during radiation. Sci Immunol. 2021 05 07; 6(59).
-
Lysophosphatidic acid induces tumor necrosis factor-alpha to regulate a pro-inflammatory cytokine network in ovarian cancer. FASEB J. 2020 10; 34(10):13935-13948.
-
Maternal administration of probiotics promotes gut development in mouse offsprings. PLoS One. 2020; 15(8):e0237182.
-
A novel Cre-enabled tetracycline-inducible transgenic system for tissue-specific cytokine expression in the zebrafish: CETI-PIC3. Dis Model Mech. 2020 06 26; 13(6).